Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients.

Vo, Ashley A; Choi, Jua; Cisneros, Kristen; Reinsmoen, Nancy; Haas, Mark; Ge, Shili; Toyoda, Mieko; Kahwaji, Joseph; Peng, Alice; Villicana, Rafael; Jordan, Stanley C

Vo, Ashley A; Choi, Jua; Cisneros, Kristen; Reinsmoen, Nancy; Haas, Mark; Ge, Shili; Toyoda, Mieko; Kahwaji, Joseph; Peng, Alice; Villicana, Rafael; Jordan, Stanley C.

Affiliation

Vo AA; 1 Comprehensive Transplant Center, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, CA. 2 HLA Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA. 3 Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA. 4 Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA. 5 Address correspondence to: Stanley C. Jordan, M.D., David Geffen School of Medicine at UCLA and Kidney Transplant Program, Cedars-Sinai Medical Center, Lo

Transplantation ; 98(3): 312-9, 2014 Aug 15.

Article in En | MEDLINE | ID: mdl-24770617

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Desensitization, Immunologic / Kidney Transplantation / Immunoglobulins, Intravenous / Antibodies, Monoclonal, Murine-Derived Type of study: Clinical_trials / Guideline Limits: Female / Humans / Male Language: En Journal: Transplantation Year: 2014 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google